FTC Pulls Back From Prior Support for Pharmacy Benefit Middlemen
Newswire
Congress Voices Bipartisan Support for FTC’s Fight Against Monopoly Power
House committee approves PBM transparency bills
How to Fix the National Drug Shortage
Bipartisan support on key panel for crackdown on pharmaceutical middlemen
US Officials Probe a New Layer in Opaque Drug Pricing, Supply System
A More Aggressive FTC Is Starting to Target Drug Mergers and Industry Middlemen
PBM landscape in for a shakeup
FTC Deepens Inquiry into Prescription Drug Middlemen
Prescription-drug costs in spotlight as pharmacy benefit reform advances in Senate
Will Senate Hearing Expose PBMs’ Unscrupulous Drug Pricing Tactics?
Another powerful congressional committee is ready to take on PBMs
Bipartisan Senate plan would regulate PBM compensation, target ‘unfair’ drug price hikes
Move the Pharmacy Benefit Manager Transparency Act of 2022 forward
National Poll Shows Overwhelming Support for Congressional Efforts to Hold PBMs Accountable
Senate Commerce approves PBM transparency bill
Pharmacy-benefit managers could face more SD regs
OK Commissioner Mulready sets record straight about changes to prescription program
Congress Investigates How Pharma Middlemen Affect Drug Prices
Corporations try to kill Oklahoma rule that aims to keep prescription temperatures safe
We Need Your Support Today!